The Dividend Yield as of December 2024 (TTM) for MoonLake Immunotherapeutics (MLTX) is 0%

According to MoonLake Immunotherapeutics’s latest financial reports and current stock price. The company's current Dividend Yield is 0%. This represents a change of 0% compared to the average of 0% of the last 4 quarters.

MoonLake Immunotherapeutics (MLTX) Historical Dividend Yield (quarterly & annually)

How has MLTX Dividend Yield performed in the past?

The mean historical Dividend Yield of MoonLake Immunotherapeutics over the last ten years is 0%. The current 0% Dividend Yield has changed 0% with respect to the historical average. Over the past ten years (40 quarters), MLTX's Dividend Yield was at its highest in in the December 2020 quarter at 0%. The Dividend Yield was at its lowest in in the December 2020 quarter at 0%.

MoonLake Immunotherapeutics (MLTX) Dividend Yield by Quarter and Year

Discovering the peaks and valleys of MoonLake Immunotherapeutics Dividend Yield, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

MoonLake Immunotherapeutics (MLTX) Average Dividend Yield

How has MLTX Dividend Yield performed in the past?

The current Dividend Yield of MoonLake Immunotherapeutics (MLTX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

MoonLake Immunotherapeutics (MLTX) Dividend Yield vs. Peers

How is MLTX’s Dividend Yield compared to its peers?

MoonLake Immunotherapeutics’s Dividend Yield is less than Terns Pharmaceuticals, Inc. (0%), less than Day One Biopharmaceuticals, Inc. (0%), less than Acumen Pharmaceuticals, Inc. (0%), less than Amylyx Pharmaceuticals, Inc. (0%), less than Aerovate Therapeutics, Inc. (0%), less than Enliven Therapeutics, Inc. (0%), less than Structure Therapeutics Inc. (0%), less than Compass Therapeutics, Inc. (0%), less than Ventyx Biosciences, Inc. (0%), less than Nuvalent, Inc. (0%), less than Cerevel Therapeutics Holdings, Inc. (0%), less than Travere Therapeutics, Inc. (0%), less than Arcellx, Inc. (0%), less than Akero Therapeutics, Inc. (0%), less than 89bio, Inc. (0%), less than Pliant Therapeutics, Inc. (0%), less than null (0%),

Build a custom stock screener for MoonLake Immunotherapeutics (MLTX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like MoonLake Immunotherapeutics using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

MoonLake Immunotherapeutics (MLTX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like MoonLake Immunotherapeutics or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.